APA (7th ed.) Citation

Bošnjak, S. M., & Jordan, K. (2018). Efficacy and safety of oral NEPA (Netupitant/Palonosetron), the first fixed-combination antiemetic, in patients with gynecological cancers receiving platinum-based chemotherapy. International journal of gynecological cancer, 28(6), . https://doi.org/10.1097/IGC.0000000000001292

Chicago Style (17th ed.) Citation

Bošnjak, Snežana M., and Karin Jordan. "Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-combination Antiemetic, in Patients with Gynecological Cancers Receiving Platinum-based Chemotherapy." International Journal of Gynecological Cancer 28, no. 6 (2018). https://doi.org/10.1097/IGC.0000000000001292.

MLA (9th ed.) Citation

Bošnjak, Snežana M., and Karin Jordan. "Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-combination Antiemetic, in Patients with Gynecological Cancers Receiving Platinum-based Chemotherapy." International Journal of Gynecological Cancer, vol. 28, no. 6, 2018, https://doi.org/10.1097/IGC.0000000000001292.